United States Breast Cancer Therapeutics Drugs Market Report 2017

United States Breast Cancer Therapeutics Drugs Market Report 2017

1 Breast Cancer Therapeutics Drugs Overview

1.1 Product Overview and Scope of Breast Cancer Therapeutics Drugs

1.2 Classification of Breast Cancer Therapeutics Drugs

1.2.1 Mitotic Inhibitors

1.2.2 Anti-metabolites

1.2.3 Zoladex

1.2.4 Aromatase Inhibitors

1.2.5 HER2 Inhibitors

1.3 Application of Breast Cancer Therapeutics Drugs

1.3.1 Hospital

1.3.2 Medical Research Laboratory

1.3.3 Others

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Breast Cancer Therapeutics Drugs (2012-2022)

1.4.1 United States Breast Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)

1.4.2 United States Breast Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

2 United States Breast Cancer Therapeutics Drugs Competition by Manufacturers

2.1 United States Breast Cancer Therapeutics Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Breast Cancer Therapeutics Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Breast Cancer Therapeutics Drugs Average Price by Manufactures (2015 and 2016)

2.4 Breast Cancer Therapeutics Drugs Market Competitive Situation and Trends

2.4.1 Breast Cancer Therapeutics Drugs Market Concentration Rate

2.4.2 Breast Cancer Therapeutics Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Breast Cancer Therapeutics Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Breast Cancer Therapeutics Drugs Sales and Market Share by States (2012-2017)

3.2 United States Breast Cancer Therapeutics Drugs Revenue and Market Share by States (2012-2017)

3.3 United States Breast Cancer Therapeutics Drugs Price by States (2012-2017)

4 United States Breast Cancer Therapeutics Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Breast Cancer Therapeutics Drugs Sales and Market Share by Type (2012-2017)

4.2 United States Breast Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Breast Cancer Therapeutics Drugs Price by Type (2012-2017)

4.4 United States Breast Cancer Therapeutics Drugs Sales Growth Rate by Type (2012-2017)

5 United States Breast Cancer Therapeutics Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Breast Cancer Therapeutics Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Breast Cancer Therapeutics Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Breast Cancer Therapeutics Drugs Manufacturers Profiles/Analysis

6.1 Bayer HealthCare

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.1.2.1 Mitotic Inhibitors

6.1.2.2 Anti-metabolites

6.1.3 Bayer HealthCare Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Eli Lily

6.2.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.2.2.1 Mitotic Inhibitors

6.2.2.2 Anti-metabolites

6.2.3 Eli Lily Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Pfizer

6.3.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.3.2.1 Mitotic Inhibitors

6.3.2.2 Anti-metabolites

6.3.3 Pfizer Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Novartis

6.4.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.4.2.1 Mitotic Inhibitors

6.4.2.2 Anti-metabolites

6.4.3 Novartis Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Eisai

6.5.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.5.2.1 Mitotic Inhibitors

6.5.2.2 Anti-metabolites

6.5.3 Eisai Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Halozyme Therapeutics

6.6.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.6.2.1 Mitotic Inhibitors

6.6.2.2 Anti-metabolites

6.6.3 Halozyme Therapeutics Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Roche

6.7.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.7.2.1 Mitotic Inhibitors

6.7.2.2 Anti-metabolites

6.7.3 Roche Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Puma Biotechnology

6.8.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.8.2.1 Mitotic Inhibitors

6.8.2.2 Anti-metabolites

6.8.3 Puma Biotechnology Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Janssen Biotech

6.9.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.9.2.1 Mitotic Inhibitors

6.9.2.2 Anti-metabolites

6.9.3 Janssen Biotech Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 AbbVie

6.10.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification

6.10.2.1 Mitotic Inhibitors

6.10.2.2 Anti-metabolites

6.10.3 AbbVie Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 BioMarin

6.12 Array BioPharma

6.13 Merck

6.14 Syndax

6.15 MacroGenics

7 Breast Cancer Therapeutics Drugs Manufacturing Cost Analysis

7.1 Breast Cancer Therapeutics Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Breast Cancer Therapeutics Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Breast Cancer Therapeutics Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Breast Cancer Therapeutics Drugs Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Breast Cancer Therapeutics Drugs Market Forecast (2017-2022)

11.1 United States Breast Cancer Therapeutics Drugs Sales, Revenue Forecast (2017-2022)

11.2 United States Breast Cancer Therapeutics Drugs Sales Forecast by Type (2017-2022)

11.3 United States Breast Cancer Therapeutics Drugs Sales Forecast by Application (2017-2022)

11.4 Breast Cancer Therapeutics Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Breast Cancer Therapeutics Drugs

Table Classification of Breast Cancer Therapeutics Drugs

Figure United States Sales Market Share of Breast Cancer Therapeutics Drugs by Type in 2015

Figure Mitotic Inhibitors Picture

Figure Anti-metabolites Picture

Figure Zoladex Picture

Figure Aromatase Inhibitors Picture

Figure HER2 Inhibitors Picture

Table Application of Breast Cancer Therapeutics Drugs

Figure United States Sales Market Share of Breast Cancer Therapeutics Drugs by Application in 2015

Figure Hospital Examples

Figure Medical Research Laboratory Examples

Figure Others Examples

Figure United States Breast Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)

Figure United States Breast Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Table United States Breast Cancer Therapeutics Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Breast Cancer Therapeutics Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Breast Cancer Therapeutics Drugs Sales Share by Manufacturers

Figure 2016 Breast Cancer Therapeutics Drugs Sales Share by Manufacturers

Table United States Breast Cancer Therapeutics Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Breast Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Breast Cancer Therapeutics Drugs Revenue Share by Manufacturers

Table 2016 United States Breast Cancer Therapeutics Drugs Revenue Share by Manufacturers

Table United States Market Breast Cancer Therapeutics Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Breast Cancer Therapeutics Drugs Average Price of Key Manufacturers in 2015

Figure Breast Cancer Therapeutics Drugs Market Share of Top 3 Manufacturers

Figure Breast Cancer Therapeutics Drugs Market Share of Top 5 Manufacturers

Table United States Breast Cancer Therapeutics Drugs Sales by States (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Sales Share by States (2012-2017)

Figure United States Breast Cancer Therapeutics Drugs Sales Market Share by States in 2015

Table United States Breast Cancer Therapeutics Drugs Revenue and Market Share by States (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Revenue Share by States (2012-2017)

Figure Revenue Market Share of Breast Cancer Therapeutics Drugs by States (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Price by States (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Sales by Type (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Sales Share by Type (2012-2017)

Figure United States Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2015

Table United States Breast Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Breast Cancer Therapeutics Drugs by Type (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Price by Type (2012-2017)

Figure United States Breast Cancer Therapeutics Drugs Sales Growth Rate by Type (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Sales by Application (2012-2017)

Table United States Breast Cancer Therapeutics Drugs Sales Market Share by Application (2012-2017)

Figure United States Breast Cancer Therapeutics Drugs Sales Market Share by Application in 2015

Table United States Breast Cancer Therapeutics Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Breast Cancer Therapeutics Drugs Sales Growth Rate by Application (2012-2017)

Table Bayer HealthCare Basic Information List

Table Bayer HealthCare Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Bayer HealthCare Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Eli Lily Basic Information List

Table Eli Lily Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eli Lily Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Eisai Basic Information List

Table Eisai Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eisai Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Halozyme Therapeutics Basic Information List

Table Halozyme Therapeutics Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Halozyme Therapeutics Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Roche Basic Information List

Table Roche Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Roche Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Puma Biotechnology Basic Information List

Table Puma Biotechnology Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Puma Biotechnology Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Janssen Biotech Basic Information List

Table Janssen Biotech Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Janssen Biotech Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table AbbVie Basic Information List

Table AbbVie Breast Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table AbbVie Breast Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table BioMarin Basic Information List

Table Array BioPharma Basic Information List

Table Merck Basic Information List

Table Syndax Basic Information List

Table MacroGenics Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Breast Cancer Therapeutics Drugs

Figure Manufacturing Process Analysis of Breast Cancer Therapeutics Drugs

Figure Breast Cancer Therapeutics Drugs Industrial Chain Analysis

Table Raw Materials Sources of Breast Cancer Therapeutics Drugs Major Manufacturers in 2015

Table Major Buyers of Breast Cancer Therapeutics Drugs

Table Distributors/Traders List

Figure United States Breast Cancer Therapeutics Drugs Production and Growth Rate Forecast (2017-2022)

Figure United States Breast Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Table United States Breast Cancer Therapeutics Drugs Production Forecast by Type (2017-2022)

Table United States Breast Cancer Therapeutics Drugs Consumption Forecast by Application (2017-2022)

Table United States Breast Cancer Therapeutics Drugs Sales Forecast by States (2017-2022)

Table United States Breast Cancer Therapeutics Drugs Sales Share Forecast by States (2017-2022)